280
Participants
Start Date
May 10, 2017
Primary Completion Date
August 3, 2018
Study Completion Date
August 3, 2018
spinosad topical suspension, 0.9%
Topically apply 0.9% suspension up to 120 mL (enough to cover the body from the neck down to the soles of the feet). One application for six hours.
Placebo
Placebo is the same as the drug minus the active ingredient spinosad (vehicle). Topically apply up to 120 mL (enough to cover the body from the neck down to the soles of the feet). One application for six hours.
DermDox Centers for Dermatology, Hazleton
Paddington Testing Company, Philadelphia
The Chappel Group Research, Kissimmee
West Houston Clinical Research Service, Houston
Discovery Clinical Trials, McAllen
Long Beach Clinical Trial Services, Long Beach
Saint Joseph's Clinical Research, Anaheim
Lead Sponsor
Collaborators (1)
Concentrics Research
OTHER
ParaPRO LLC
INDUSTRY